Spark Investment Management LLC Biogen Inc. Transaction History

Spark Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $8.74 Million - $9.8 Million	-40,200 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$219.29 - $241.72 $8.82 Million - $9.72 Million	40,200 New	40,200 $9.4 Million
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $8.19 Million - $10.4 Million	-29,400 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $3.79 Million - $4.95 Million	-12,900 Reduced 30.5%	29,400 $10.4 Million
Q2 2018 Aug 08, 2018	BUY	$257.52 - $306.91 $566,544 - $675,202	2,200 Added 5.49%	42,300 $12.3 Million
Q1 2018 May 10, 2018	BUY	$260.13 - $367.91 $1.2 Million - $1.69 Million	4,600 Added 12.96%	40,100 $11 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $9.98 Million - $11.7 Million	35,500	35,500 $11.1 Million

1,036

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.